Skip to main content
News Directory 3
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World

One Dose Antibiotic Treats Early Syphilis

September 3, 2025 Dr. Jennifer Chen Health

Okay, here’s a draft article based on the provided text, incorporating the guidelines. I’ve aimed for a balance of SEO, user value, and adherence to the specified components. I’ve also included ⁣suggestions for expansion where indicated. This is a draft ‌ and would benefit from further research​ and expert input (especially for⁢ the “Editor’s Analysis” section).


Single Syphilis Shot as Effective as Three, NIH Trial Finds

Table of Contents

  • Single Syphilis Shot as Effective as Three, NIH Trial Finds
    • Rising Syphilis Rates & Treatment Challenges
    • Understanding syphilis
    • BPG Shortages & Treatment Access
    • Study Details

(Last updated: September 3, 2025)

What: A new NIH-funded ⁣clinical trial shows a single injection of benzathine penicillin G (BPG) ​is as effective as the standard three-dose regimen for treating early-stage syphilis.
Where: Conducted at ten ‍sites across ⁤the United States.
When: Results published September 3, 2025, in The ‍New England Journal of‍ Medicine.
Why it Matters: ⁢Simplifies treatment,possibly improving adherence and combating rising syphilis rates. Addresses BPG shortages.
What’s next: Further evaluation and potential updates to treatment guidelines.

Researchers funded by the National Institutes of Health (NIH) ‍have demonstrated that a single injection of ⁤the antibiotic benzathine penicillin G (BPG) is​ just as effective in treating early syphilis as the conventional ‌three-injection regimen. ‌ The findings, published today in The New England Journal of​ Medicine, suggest that the second and third doses of conventional BPG therapy may not provide additional‌ health benefits.

Rising Syphilis Rates & Treatment Challenges

Syphilis rates ⁤are increasing dramatically in the United States. In 2023, the U.S.reported 209,253 total syphilis cases and 3,882 congenital syphilis cases, representing 61% and 108% increases over 2019 numbers, ‌respectively. This surge underscores ‌the urgent need for effective and accessible treatment options.

“Benzathine penicillin G is highly effective against syphilis, but the three-dose regimen can be burdensome and deter ⁣people from ⁤attending follow-up visits with their healthcare providers,” said Carolyn Deal, Ph.D., chief of the enteric and sexually transmitted infections branch of NIH’s National Institute of Allergy and Infectious Diseases⁣ (NIAID). “The new ​findings offer ​welcome evidence for potentially simplifying treatment with an equally effective one-dose regimen, notably​ while syphilis rates remain alarmingly high.”

Understanding syphilis

Syphilis is a common sexually ‌transmitted infection (STI) caused by the bacterium Treponema pallidum. ​ Without treatment, syphilis⁤ can lead to serious health complications, including neurological and organ damage,​ severe pregnancy complications, congenital abnormalities in ⁤newborns, and an increased risk of acquiring‌ or transmitting HIV.

The disease progresses through several stages:

  • Primary Syphilis: Characterized by a painless sore ⁤called a chancre.
  • Secondary Syphilis: May involve a rash,fever,and swollen lymph ⁢nodes.
  • Early Latent Syphilis: No visible signs or symptoms, ​but the infection remains​ in the body.

Early diagnosis and treatment are crucial to prevent progression to later, more severe ⁢stages. ​ More information on symptoms and ​stages can be found BPG Shortages & Treatment Access

BPG is a ‌critical antibiotic for treating syphilis, but global Study Details

The clinical trial involved 249 participants with early ⁢syphilis (primary, secondary, or early latent stages) at ten U.S. sites. The participant ​demographics were as follows:

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

antibiotic, dose, early, NIAID, NIH, Research, Syphilis, TREATS?

Search:

News Directory 3

ByoDirectory is a comprehensive directory of businesses and services across the United States. Find what you need, when you need it.

Quick Links

  • Copyright Notice
  • Disclaimer
  • Terms and Conditions

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

Connect With Us

© 2026 News Directory 3. All rights reserved.

Privacy Policy Terms of Service
Characteristic Percentage